Hostname: page-component-586b7cd67f-2plfb Total loading time: 0 Render date: 2024-11-24T23:26:53.889Z Has data issue: false hasContentIssue false
  • English
  • Français

Prejudice and the Medical Profession: A Five-Year Update

Published online by Cambridge University Press:  01 January 2021

Peter A. Clark
Get access Rights & Permissions [Opens in a new window]

Extract

Over the past decades the mortality rate in the United States has decreased and life expectancy has increased. Yet a number of recent studies have drawn Americans attention to the fact that racial and ethnic disparities persist in health care. It is clear that the U.S. health care system is not only flawed for many reasons including basic injustices, but may be the cause of both injury and death for members of racial and ethnic minorities.

In 2002, an Institute of Medicine (IOM) report requested by Congress listed more than 100 studies documenting a wide range of disparities in the United States health care system. This report found that people belonging to racial and ethnic minorities often receive lower quality of health care than do people of European descent, even when their medical insurance coverage and income levels are the same as that of the latter.

Type
Symposium
Information
Journal of Law, Medicine & Ethics , Volume 37 , Issue 1 , Spring 2009 , pp. 118 - 133
Copyright
Copyright © American Society of Law, Medicine and Ethics 2009

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Committee on Understanding and Eliminating Racial and Ethnic Disparities in Health Care, Institute of Medicine, Unequal Treatment: What Healthcare Providers Need to Know about Racial and Ethnic Disparities in Health Care (Washington, D.C.: National Academy Press, 2002).Google Scholar
Gifford, A. Cunningham, W. Heslin, K., “Participation in Research and Access to Experimental Treatments by HIV-Infected Patients,” New England Journal of Medicine 346, no. 18 (May 2, 2002): 1373–1382.CrossRefGoogle Scholar
Corbie-Smith, G. Thomas, S. St. George, D., “Distrust, Race, and Research,” Archives of Internal Medicine 162, no. 21 (November 25, 2002): 2458–2463.CrossRefGoogle Scholar
The term “medical profession” is a social construct and in this paper is being used in a broad sense. The medical profession is comprised of millions of individuals in which, many may be racist and insensitive, but there are many of whom are not racist. For lack of a better term, the term “medical profession” will be used to designate medical professionals in the United States knowing full well not all are being deemed racist.Google Scholar
See Committee on Understanding and Eliminating Racial and Ethnic Disparities in Health Care, supra note 1, at 4.Google Scholar
United States Department of Health and Human Services, Agency for Healthcare Research and Quality (AHRQ), 2007 National Healthcare Disparities Report, Washington, D.C., February 2008.Google Scholar
The Tuskegee Syphilis Study will be discussed in more depth later in this article. For a more detailed analysis of the Tuskegee Syphilis Study see, Jones, J. H., Bad Blood: The Tuskegee Syphilis Experiment — A Tragedy of Race and Medicine (New York: The Free Press, 1981).Google Scholar
Allport, G. W. Postman, L., The Psychology of Rumor (New York: Henry Holt, 1947): At ix.Google Scholar
Turner, P., I Heard It Through the Grapevine: Rumor in African American Culture (Berkeley: University of California Press, 1993): at 4.Google Scholar
Id., at 5.Google Scholar
Allport and Postman make a case that legends are often little more than solidified rumors. See Allport, Postman, , supra note 8, at167.Google Scholar
Id., at xv and 108.Google Scholar
See Turner, , supra note 9, at 138.Google Scholar
Gamble, V., “A Legacy of Distrust: African Americans and Medical Research,” American Journal of Preventative Medicine 9, no. 6, Supplement (1993): 35–38.CrossRefGoogle Scholar
Id., at 35. See also, Weld, T. D., American Slavery As It Is: Testimony of a Thousand Witnesses (New York: 1939); Boone, F. N., Dr. Thomas Hamilton: Two Views of a Gentleman of the Old South (New York: Phylon, 1967); and Sims, J. M., The Story of My Life (New York: Appleton, 1998).Google Scholar
Id., at 35–36.Google Scholar
For a more detailed analysis of the influence of the Paris school on American medicine, see Ackerknecht, E., Medicine at the Paris Hospital, 1794–1848 (Baltimore: Johns Hopkins Press, 1967); Shryock, R., The Development of Modern Medicine: An Interpretation of the Social and Scientific Factors Involved (New York: Elsevier 1947); Foucault, M., The Birth of the Clinic: An Archeology of Medical Perception (New York: Routledge Classics, 1973); and Gerald, G., Edward Garvis and the Medical World of Nineteenth Century America (Knoxville: Turner, 1978).Google Scholar
Savitt, T., “The Use of Blacks for Medical Experimentation and Demonstration in the Old South,” Journal of Southern History 48, no. 3 (1972): 332–333.Google Scholar
Id., at 333.Google Scholar
Fry, G.-M., Night Riders in Black Folk History (Athens, GA: University of Georgia Press, 1991): At 174–176.Google Scholar
Id., at 174–178.Google Scholar
Id., at 176. See also Guttmacher, , “Bootlegging Bodies,” Society of Medical History of Chicago 4, no. 2 (January 1935): 353–402.Google Scholar
Id. (Fry), at 171.Google Scholar
For a more detailed analysis of the black migration to industrial centers, see Henderson, D., “The Negro Migration of 1916–1918,” Journal of Negro History 6, no. 2 (January 1921): 383–498.Google Scholar
See Fry, , supra note 20, at 171.Google Scholar
Id., at 172.Google Scholar
Humphrey, D. C., “Dissection and Discrimination: The Social Origins of Cadavers in America, 1760–1915,” Bulletin of the New York Academy of Medicine 44, no. 9 (1970): 819–827, at 822. Humphrey also cites Sozinsky, T. S., “Grave-Robbing and Dissection,” Penn Monthly 19 (1879): 216.Google Scholar
Id. (Humphrey), at 824.Google Scholar
Id., at 824–825.Google Scholar
See Gamble, , supra note 14, at 36.Google Scholar
Id., at 36. See also, Murrell, T. W., “Syphilis and the American Negro,” Journal of the American Medical Association 54, no. 10 (1910): 846–849 at 847; and Hazen, H. H., “Syphilis in the American Negro,” Journal of the American Medical Association 63, no. 6 (1914): 463–468 at 463.CrossRefGoogle Scholar
Caldwell, J. G. Price, E. V., “Aortic Regurgitation in the Tuskegee Study of Untreated Syphilis,” Journal of Chronic Diseases 26, no. 3 (1973): 187–99; Hiltner, S., “The Tuskegee Syphilis Study under Review,” Christ Century 90, no. 43 (1973): 1174–1176; Kampmeier, R. H., “The Tuskegee Study of Untreated Syphilis,” South Medical Journal 65, no. 10 (1972): 1247–1251; Kampmeier, R. H., “Final Report on the ‘Tuskegee Syphilis Study,’” South Medical Journal 67, no. 11 (1974): 1349–1353; Olansky, S. Simpson, L., “Environmental Factors in the Tuskegee Study of Untreated Syphilis,” Public Health Report 69, no. 7 (1954): 691–698; Rockwell, D. H. Yobs, A. R., “The Tuskegee Study of Untreated Syphilis: The 30th Year of Observation,” Archives of Internal Medicine 114 (1964): 792–798; Schuman, S. H. Olansky, S., “Untreated Syphilis in the Male Negro: Background and Current Status of Patients in the Tuskegee Study,” Journal of Chronic Diseases 2, no. 5 (1955): 543–58.CrossRefGoogle Scholar
In August, 1972, HEW appointed an investigatory panel which issued a report the following year. The panel found the study to have been “ethically unjustified” and argued that penicillin should have been provided. See Brandt, A., “Racism and Research: The Case of the Tuskegee Syphilis Study,” Hastings Center Report 8, no. 6 (December 1978): 21–29 at 21; and Ad Hoc Advisory Panel, Department of Health, Education and Welfare, Final Report of the Tuskegee Syphilis Study (Washington, D.C.: Government Printing Office, 1973). For a more detailed analysis of the Tuskegee Syphilis Study see, Caplan, A., “When Evil Intrudes,” Hastings Center Report 22, no. 2 (November-December 1992): 29–32; Edgar, H., “Outside the Community,” Hastings Center Report 22, no. 6 (November-December 1992): 32–35; King, P. A., “The Dangers of Difference,” Hastings Center Report 22, no. 6 (November-December 1992): 35–38; and Jones, J. H., “The Tuskegee Legacy: AIDS and the Black Community,” Hastings Center Report 22, no. 6 (November-December 1992): 38–40.Google Scholar
For a more detailed analysis of the impact of birth control on the African American community, see Weisbord, R. G., “Birth Control and the Black American: A Matter of Genocide?” Demography 10, no. 3 (1973): 571–590.CrossRefGoogle Scholar
Norplant is the trade name for a birth control product consisting of six thin capsules that, upon being implanted in the woman's arm, releases an ovulation-inhibiting hormone. See Turner, , supra note 9, at 221.Google Scholar
Id., at 222. See also, Editor, “One Well-Read Editorial,” Newsweek 31, December 1990, at 65–66; and Kimelman, D., “Poverty and Norplant,” Philadelphia Inquirer 12, December 1990, at A-18.Google Scholar
Abate, T., “Brave New World of Genetics Explored at Academy of Science Meeting,” San Francisco Chronicle, February 25, 2002, E-1.Google Scholar
Id., at E-1.Google Scholar
For a more detailed analysis of the effects of race on medical care see, Geiger, J. H., “Race and Health Care: An American Dilemma,” New England Journal of Medicine 335, no. 12 (1996): 815–816; Gornick, M. E. Eggers, P. W. Reilly, T. W., “Effects of Race and Income on Mortality and Use of Services among Medicare Beneficiaries,” New England Journal of Medicine 335, no. 11 (1996): 791–799.CrossRefGoogle Scholar
Wilkenson, D. Y., “For Whose Benefit?: Politics and Sickle Cell Anemia,” The Black Scholar 5, no. 8 (1974): 26–31. See also King, , supra note 33, at 37.CrossRefGoogle Scholar
Id.Google Scholar
Id. (Wilkenson, ), at 30.Google Scholar
See Curtis, C., Vaccines Are Dangerous: A Warning to the Black Community (Brooklyn: A&B Books, 1991).Google Scholar
O'Connor, B., “Foundations of African-American Mistrust of the Medical Establishment,” unpublished manuscript, Hahnemann University Medical School, Philadelphia, Pennsylvania, at 10–11.Google Scholar
A national survey, conducted by the Roper Starch Worldwide polling company, found that out of 500 blacks, 18% said they believed AIDS was a man-made virus; 9% in the general population agreed. When asked more specifically whether HIV and AIDS were part of a plot to kill blacks, 9% of the all-black group said it was definitely true; compared to 1% in the general group. See Richardson, L., “An Old Experiment's Legacy: Distrust of AIDS Treatment,” New York Times, April 21, 1997, at A-9.Google Scholar
See Gamble, , supra note 14, at 37. See also, Thomas, S. B. Quinn, S. C., “The Tuskegee Syphilis Study, 1932 to 1972: Implications for HIV Education and AIDS Risk Education Programs in the Black Community,” New York Times, April 21, 1997, at A-9.Google Scholar
See Turner, , supra note 9, at 158. See also Kloniff, E. A. Landrine, H., “Do Blacks Believe That HIV/AIDS Is a Government Conspiracy against Them?” Preventative Medicine 28, no. 4 (1998): 451–457; Corbie-Smith, G. Thomas, S. B. Williams, M. V. Moody-Ayers, S., “Attitudes and Beliefs of African Americans toward Participation in Medical Research,” Journal of General Internal Medicine 14, no. 9 (1999): 537–546.Google Scholar
Cneters for Disease Control, “HIV/AIDS in the United States-Fact Sheet,” March 2008, at 1–5, available at <http://www.cdc.gov/hiv/resources/factsheets/print/us.htm> (last visited January 9, 2009).+(last+visited+January+9,+2009).>Google Scholar
It should be noted that “age, sex, diet, underlying disease, and the concomitant use of other medications, race and genetic factors may play pivotal parts in the variability of subjects' responses to a medication.” See King, T., “Racial Disparities in Clinical Trials,” New England Journal of Medicine 346, no. 18 (May 2, 2002): 1400–1402.CrossRefGoogle Scholar
See Gifford, , supra 2, at 1373–1382.Google Scholar
Id., at 1376–1379. The NIH and the FDA both established guidelines encouraging inclusion of more women and minority groups in clinical trials. See, National Institutes of Health, “Guidelines on the Inclusion of Women and Minorities as Subjects in Clinical Trials,” Federal Register 59 (1994): 14508–14513; and Food and Drug Administration, Modernization Act of 1997 (FDAMA or the Act), Public Law No. 105–115 (November 21, 1997). It should be noted that experts at the NIH challenged the findings of Gifford, , saying that because the study was based on patient interviews in 1996–1998, it was therefore out of date.Google Scholar
See Gifford, , supra note 2, at 1379.Google Scholar
See Corbie-Smith, , supra note 3, at 2458–2463.Google Scholar
See King, , supra note 49, at 1402.Google Scholar
Id., at 1402. See also Fogarty, L. Roter, D. Larson, S., “Patient Adherence to HIV Medication Regimens: A Review of Published and Abstract Reports,” Patient Education Council 46, no. 2 (2002): 93–108.CrossRefGoogle Scholar
See King, , supra note 49, at 1401.Google Scholar
Merz, J., “Report Claims Clinical Trials Miss Many Populations,” Washington Post, April 3, 2008, available at <http://www.irbforum.org/forum/read/2/167/167Vt?PHPSESSID=656c640dfe552e73efb2e3877c277473> (last visited December 11, 2008).Google Scholar
See Committee on Understanding and Eliminating Racial and Ethnic Disparities in Health Care, supra note 1, at 2.Google Scholar
Id., at 3–4.Google Scholar
United States Department of Health and Human Services, Agency for Healthcare Research and Quality (AHRQ), supra note 6, at 5–6.Google Scholar
Id., at 6.Google Scholar
Id., at 7.Google Scholar
Williams, D. Gonzalez, H. Neighbors, H., “Prevalence and Distribution of Major Depressive Disorder in African Americans, Caribbean Blacks, and Non-Hispanic Whites,” Archives of General Psychiatry 64, no. 3 (March 2007): 305–315.CrossRefGoogle Scholar
Halpern, M. Ward, E. Pavluck, A., “Association of Insurance Status and Ethnicity with Cancer Stage at Diagnosis for 12 Cancer Sites: A Retrospective Analysis,” Lancet Oncology 9, no. 3 (March 2008): 222–231.CrossRefGoogle Scholar
Powe, N., “Black Americans Still Wary of Clinical Trials,” Medicine Online (January 14, 2008), available at <http://www.medicineonline.com/news/12/10849/Black-Americans-Still-Wary-0f-clinical> (last visited December 11, 2008).Google Scholar
Editor, “Did Tuskegee Damage Trust On Clinical Trials?” CNN.com, March 19, 2008, available at <http://www.cnn.com/2008/HEALTH/03/17/clinical.trials.ap/index.html> (last visited December 11, 2008).+(last+visited+December+11,+2008).>Google Scholar
Sequist, T. Fitzmaurice, G. M. Marshall, R., “Physician Performance and Racial Disparities in Diabetes Mellitus Care,” Archives of Internal Medicine 168, no. 11 (June 9, 2008): 1145–1151; and Minnema, L. “Race May Limit Care,” Washington Post, June 17, 2008, available at <http://www.washingtonpost.com/wp-dyn/content/article/2008/06/13/AR2008061303263> (last visited December 22, 2008).CrossRefGoogle Scholar
Id. (Sequist, ), at 1145. See also Schulman, K. A. Berlin, J. A. Halrell, W., “The Effect of Race and Sex on Physicians' Recommendations for Cardiac Catheterization,” New England Journal of Medicine 340, no. 8 (1999): 618–626; Abreu, J. M., “Conscious and Nonconscious African American Stereotypes: Impact on First Impression and Diagnostic Ratings by Therapists,” Journal of Consulting and Clinical Psychology 67, no. 3 (1999): 387–393; and Van Ryn, M. Burke, J., “The Effect of Patient Race and Socio-Economic Status on Physician's Perceptions of Patients,” Social Science and Medicine 50, no. 6 (2000): 813–828.Google Scholar
Satcher, D., “Our Commitment to Eliminate Racial and Ethnic Health Disparities,” Yale Journal of Health Policy, Law, and Ethics 1, no. 1 (2001): 1–14.Google Scholar
Id., at 1.Google Scholar
National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research, The Belmont Report: Ethical Principles and Guidelinesfor the Protection of Human Subjects of Research (Washington, D.C.: U. S. Government Printing Office, 1979): At B-1.Google Scholar
Pellegrino, E. D. Thomasma, D. C., A Philosophical Basis of Medical Practice (New York: Oxford University Press, 1981): at 213.Google Scholar
See Committee on Understanding and Eliminating Racial and Ethnic Disparities in Health Care, supra note 1, at 2.Google Scholar
See Corbie-Smith, , supra note 3, at 2460.Google Scholar
See Powe, , supra note 65, at 2.Google Scholar
See Gifford, , supra 2, at 1373–1375.Google Scholar
Id., at 1373.Google Scholar
See King, , supra note 28, at 1402. See also, Svensson, C. K., “Representation of American Blacks in Clinical Trials of New Drugs,” Journal of the American Medical Association 261, no. 1 (1989): 263–265.Google Scholar
Centers for Disease Control and Prevention, “United States HIV/AIDS Statistics,” HIV/AIDS Surveillance Report 13, no. 2 (June 2001): 1–4.Google Scholar
See Powe, , supra note 65. Gardner, A., “Black Americans Still Wary of Clinical Trials,” U.S. News and World Report (January 20, 2008), available at <http://health.usnews.com/usnews/health/healthday/080114/black-americanstill-wary-of-clinical-trials> (last visited December 22, 2008).Google Scholar
Barrett, G., “Deadly Delay,” Newsweek Web Exclusive (February 17, 2008), available at <http://www.newsweek.com/id/112952/output/print> (last visited December 11, 2008).Google Scholar
See United States Department of Health and Human Services, Agency for Healthcare Research and Quality (AHRQ), supra note 6, at Chapter 4, “Priority Populations,” at 1–10.Google Scholar
Gilliam, M., “Health Care Inequality Is Key in Abortion Rates,” Philadelphia Inquirer, August 10, 2008, available at <http://www.philly.com/inquirer/currents/20080811_health-care_inequality_is_key_in_abortion_rates.html?adString=ing.currents/currents;!category=currents;&randomOrd=081308104817> (last visited December 22, 2008).Google Scholar
Id., at 2.Google Scholar
U.S. Department of Health and Human Services, “Key Themes and Highlights from the National Healthcare Disparities Report,” 2007, at 1–11, available at <http://www.ahrq.gov/qual/nhdr07/Key.htm> (last visited December 11, 2008).+(last+visited+December+11,+2008).>Google Scholar
See Committee on Understanding and Eliminating Racial and Ethnic Disparities in Health Care, supra note 1, at 5–6.Google Scholar
Council on Ethical and Judicial Affairs, Code of Medical Ethics: Current Opinions with Annotations, American Medical Association, Chicago, 1998, at 9.121.Google Scholar
See Corbie-Smith, , supra note 3, at 2462.Google Scholar
Id., at 2462.Google Scholar
See U.S. Department of Health and Human Services, supra note 74, at 10.Google Scholar
Angell, M., “The Forgotten Domestic Crisis,” New York Times, October 13, 2002, at Wk-13.Google Scholar
Stolberg, S. G., “Race Gap Seen in Health Care of Equally Insured Patients,” New York Times, March 21, 2002, at A-1, A-34.Google Scholar
See Gardner, , supra note 80, at 3.Google Scholar
Cohen, E., “Tuskegee's Ghosts: Fear Hinders Black Marrow Donation,” CNN.Com, February 7, 2007, at 1–2, available at <http://www.cnn.com/2007/HEALTH/02/07/bone.marrow/index.html> (last visited January 9, 2009). (last visited January 9, 2009).' href=https://scholar.google.com/scholar?q=Cohen,+E.,+“Tuskegee's+Ghosts:+Fear+Hinders+Black+Marrow+Donation,”+CNN.Com,+February+7,+2007,+at+1–2,+available+at++(last+visited+January+9,+2009).>Google Scholar
See Barrett, , supra note 81, at 2–3.Google Scholar
Mozes, A., “Report Claims Clinical Trials Miss Many Populations,” U.S. News & World Report, April 1, 2008, available at <http://health.usnews.com/usnews/health/healthday/080401/report-claims-clinical-trials-miss-many-populations.html> (last visited April 3, 2008).Google Scholar